Day One Biopharmaceuticals, Inc. (DAWN)

Last Year

05-May-23 -- 04-May-24

Time Period:

($1.12M) Net Amount

Buy:	0	--
Sell:	($1.12M)	$15.24 - $16.11

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

11

0

2

+1

0

+2

0

+3

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Oct-23 4:02 PM View:	20-Oct-23 Purchase $1.11M	Ai Day 1 LLC 10% Owner		Day One Biopharmaceuticals, Inc. - DAWN	21% 10.68M to 12.93M	0	0	--	--	Show Txns Hide Txns

Yesterday 6:48 PM View:	Yesterday Sale (Planned) ($163.42K)	Bender Jeremy Chief Executive Officer Director		Day One Biopharmaceuticals, Inc. - DAWN	(3%) 1.74M to 1.69M	0	0	--	--	Show Txns Hide Txns

Yesterday 6:44 PM View:	Yesterday Sale (Planned) ($144.21K)	York Charles N II COO, CFO and Secretary		Day One Biopharmaceuticals, Inc. - DAWN	(17%) 262.13K to 217.29K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 6:48 PM View:	16-Feb-24 Option Sale ($49.43K)	Dubow Adam General Counsel		Day One Biopharmaceuticals, Inc. - DAWN	428% 3.14K to 16.59K	0	0	--	--	Show Txns Hide Txns

22-Apr-24 6:36 PM View:	18-Apr-24 Market Sale (Planned) ($160.16K)	Blackman Samuel C. HEAD OF R&D		Day One Biopharmaceuticals, Inc. - DAWN	(3%) 2.23M to 2.17M	0	($1.12M) (3%)	--	$15.24 - $16.11	Show Txns Hide Txns